- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01717144
Education in Therapy of Parkinson's Disease (ETPARK)
EVALUATION OF A THERAPEUTIC EDUCATION PROGRAMME IN PARKINSON'S DISEASE
Parkinson's disease (PD) has considerable impact on motor, psychological and social activities and significantly affects the quality of life of patients and their families. To improve the medical care of PD patients, the investigator have developed an educational program specific to PD.
The principal aim of this study is to evaluate the therapeutic education Program, comparing the quality of life of PD patients with or without the educational program after six month and one year follow-up.
The secondary aims are to evaluate the evolution of motor and psychological states in these 2 groups of patients and to compare the medical costs.
This is a monocentric, comparative, prospective randomised study. The investigators will evaluate 120 PD patients, 60 patients benefiting of the educational program and 60 patients with a traditional medical care. Quality of life of PD patients is evaluated using a specific scale (PDQ39) and a generalist scale (SF36) at 6 and 12 months. Motor and psychological states were assessed with UPDRS and HAD Scales. The educational program consisted of both individual and collective educational consultations.
The investigators supposed that the therapeutic education program will improve the quality of life of PD patients. The supposition that this improvement will correlate with the motor and psychological states.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Toulouse, France, 31000
- Uh Toulouse
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Patients with clinical diagnosis of Parkinson's disease according to the criteria of the UKPDSBB
- Parkinson's disease patients with a score ≤4 on the Hoehn and Year scale
- Patient without cognitive disorders
- Patients treated with dopaminergic antiparkisonian drugs (L-DOPA, dopamine agonists,ICOMT…) or DBS stimulation (since at least 3 month)
- Patients able to fulfil self-administered questionnaire
- Patients affiliated to a social protection program
Exclusion Criteria:
- - Patients suffering from an other pathology causing chronic pain (rheumatic disease, traumatic or orthopaedic pathologies…)
- Parkinson's disease patients with a score>5 on the Hoehn and Yahr scale
- Patients suffering of parkinsonism induce by drugs
- Patients with important tremors during a OFF conditions
- Patients ever included in another study
- Patients with severe psychiatric disease
- Patients under tutelage, curatelle or law protection
- Patients included in an other clinical study
- Patients unable to fulfil scales of the study
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: traditional medical care
patients benefiting of a traditional medical care
|
|
|
Expérimental: therapeutic education program
The educational program consisted of both individual and collective educational consultations with a therapeutic education nurse
|
The educational program consisted of both individual and collective educational consultations with a therapeutic education nurse
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Quality of life with the PDQ39 scale
Délai: 1 year
|
1 year
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Quality of life with the SF36 scale
Délai: 1 year
|
1 year
|
|
the motor state with UPDRS (Unified Pakinson's disease Rating Scale)
Délai: 1 year
|
1 year
|
|
The psychological state with HAD (Hospital Anxiety and Depression) scale
Délai: 1 year
|
1 year
|
|
Evaluation of social adaptation with SAS-SR (Social adjustement Scale Sel-Report) scale
Délai: 1 year
|
1 year
|
|
Evaluation of medical costs
Délai: over the 12 months follow-up
|
over the 12 months follow-up
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 08 150 07
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .